申请人:Merck, Sharp & Dohme Limited
公开号:US05559125A1
公开(公告)日:1996-09-24
A class of 4-hydroxy-2-(1H)-quinolone derivatives, substituted at the 3-position by an optionally substituted aryl substituent, are selective non-competitive antagonists of NMDA receptors and/or are antagonists of AMPA receptors, and are therefore of utility in the treatment of conditions, such as neurodegenerative disorders, convulsions or schizophrenia, which require the administration of an NMDA and/or AMPA receptor antagonist.
一类4-羟基-2-(1H)-喹啉衍生物,其在3位被可选择取代的芳基取代基所取代,是NMDA受体的选择性非竞争性拮抗剂和/或AMPA受体的拮抗剂,因此在治疗需要给予NMDA和/或AMPA受体拮抗剂的疾病,如神经退行性疾病、惊厥或精神分裂症等方面具有实用价值。